[{"NetIncomeLoss_1_Q1_USD":32100000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":12800000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":1000000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":3200000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":63100000.0,"Depreciation_1_Q1_USD":2500000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":171900000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":16000000.0,"AssetsCurrent_0_Q1_USD":1085400000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":93700000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":-1700000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":129000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":2700000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":15200000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":322000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":15500000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-800000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":161300000.0,"CommonStockSharesIssued_0_Q1_shares":94500000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":2500000.0,"Assets_0_Q1_USD":1846400000.0,"ShareBasedCompensation_1_Q1_USD":32900000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":2900000.0,"OperatingLeaseLiability_0_Q1_USD":119700000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-800000.0,"Investments_0_Q1_USD":1165400000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":156400000.0,"EarningsPerShareBasic_1_Q1_USD":0.34,"RepaymentsOfConvertibleDebt_1_Q1_USD":100000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":98200000.0,"AccountsReceivableNetCurrent_0_Q1_USD":147800000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-4900000.0,"CommonStockValue_0_Q1_USD":100000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":249600000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_security":39.0,"DebtInstrumentUnamortizedDiscountPremiumNet_0_Q1_USD":55500000.0,"DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":11000000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":15100000.0,"CostsAndExpenses_1_Q1_USD":205100000.0,"OtherAssetsCurrent_0_Q1_USD":33800000.0,"IncreaseDecreaseInInventories_1_Q1_USD":2100000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":31300000.0,"OtherAssetsNoncurrent_0_Q1_USD":1400000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":352600000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":107500000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1897800000.0,"Liabilities_0_Q1_USD":640800000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":97000000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":73200000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q1_USD":325600000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-9300000.0,"CommonStockSharesOutstanding_0_Q1_shares":94500000.0,"EarningsPerShareDiluted_1_Q1_USD":0.33,"AmortizationOfFinancingCosts_1_Q1_USD":300000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":2600000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":27200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":32900000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":87300000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":14800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":94200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":165500000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":14900000.0,"NonoperatingIncomeExpense_1_Q1_USD":-4300000.0,"InterestExpense_1_Q1_USD":6400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":355800000.0,"DeferredIncomeTaxesAndTaxCredits_1_Q1_USD":-6200000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.053,"OperatingLeasePayments_1_Q1_USD":2600000.0,"DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_0_Q1_USD":249600000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":100000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":45300000.0,"LiabilitiesCurrent_0_Q1_USD":190000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-693300000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":355800000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":4500000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"InterestReceivableCurrent_0_Q1_USD":3200000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":36700000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":15500000.0,"DebtInstrumentFaceAmount_0_Q1_USD":381200000.0,"DeferredFinanceCostsNet_0_Q1_USD":3700000.0,"CommonStockSharesAuthorized_0_Q1_shares":220000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":236600000.0,"OperatingIncomeLoss_1_Q1_USD":31500000.0,"EquitySecuritiesFvNiRestricted_0_Q1_USD":38900000.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q1_USD":520200000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":521100000.0,"InventoryNet_0_Q1_USD":30100000.0,"PreferredStockValue_0_Q1_USD":0.0,"OperatingLeaseCost_1_Q1_USD":3400000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1846400000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":3900000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":12200000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":16000000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":21300000.0,"OtherLiabilitiesCurrent_0_Q1_USD":18100000.0,"StockholdersEquity_0_Q1_USD":1205600000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":15200000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":9100000.0,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]